Concepedia

Philip Petteruti

PP

10

Publications

795

Citations

10

H-Index

2001

Active since

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

Imperial College London

Philip Petteruti is an author at AstraZeneca (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2001–2020

10

Publications

10

AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies

Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao et al. · Molecular Cancer Therapeutics · 2016 · 147 citations · Full text

, , +17

Potent and selective bivalent inhibitors of BET bromodomains

Michael J. Waring, Huawei Chen, Alfred A. Rabow et al. · Nature Chemical Biology · 2016 · 134 citations · Full text

, , +3

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6

William McCoull, Tony Cheung, Erica Anderson et al. · ACS Chemical Biology · 2018 · 133 citations · Full text

, , +14

Discovery and Mechanistic Study of a Small Molecule Inhibitor for Motor Protein KIFC1

Jiaquan Wu, Keith Mikule, Wenxian Wang et al. · ACS Chemical Biology · 2013 · 120 citations

, , +21

Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering

Jeffrey W. Johannes, Lynsie Almeida, Kevin Daly et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 62 citations · Full text

, , +5

Rows per page

1–5 of 10